Animal Models in Progressive Supranuclear Palsy Research
📖 Wiki Page
mechanism1452 wordssynced 2026-04-02
Animal Models in Progressive Supranuclear Palsy Research
Overview
Animal models are essential tools for understanding the pathogenesis of Progressive Supranuclear Palsy (PSP) and developing therapeutic interventions. Unlike Alzheimer's disease and Parkinson's disease, which have well-established animal models, PSP has presented unique challenges due to the selective vulnerability of specific neuronal populations and the 4R-tau pathology that characterizes the disease. This page provides a comprehensive overview of animal models used in PSP research, including their strengths, limitations, and contributions to our understanding of disease mechanisms.
Why Animal Models Are Critical for PSP Research
Challenges in PSP Modeling
PSP presents several unique challenges that make animal model development particularly difficult:
4R-Tau Specificity: PSP is characterized by exclusive accumulation of 4-repeat (4R) tau isoforms, while most transgenic models produce mixed 3R/4R tau
Selective Neuronal Vulnerability: Specific populations are affected (globus pallidus, subthalamic nucleus, substantia nigra pars compacta, brainstem nuclei)
Tau Strain Biology: PSP tau has distinct structural properties different from AD tau or CBD tau
Age-Dependent Onset: PSP typically presents in the sixth decade, requiring age-appropriate model systems
Research Applications
Animal models enable researchers to:
...
Animal Models in Progressive Supranuclear Palsy Research
Overview
Animal models are essential tools for understanding the pathogenesis of Progressive Supranuclear Palsy (PSP) and developing therapeutic interventions. Unlike Alzheimer's disease and Parkinson's disease, which have well-established animal models, PSP has presented unique challenges due to the selective vulnerability of specific neuronal populations and the 4R-tau pathology that characterizes the disease. This page provides a comprehensive overview of animal models used in PSP research, including their strengths, limitations, and contributions to our understanding of disease mechanisms.
Why Animal Models Are Critical for PSP Research
Challenges in PSP Modeling
PSP presents several unique challenges that make animal model development particularly difficult:
4R-Tau Specificity: PSP is characterized by exclusive accumulation of 4-repeat (4R) tau isoforms, while most transgenic models produce mixed 3R/4R tau
Selective Neuronal Vulnerability: Specific populations are affected (globus pallidus, subthalamic nucleus, substantia nigra pars compacta, brainstem nuclei)
Tau Strain Biology: PSP tau has distinct structural properties different from AD tau or CBD tau
Age-Dependent Onset: PSP typically presents in the sixth decade, requiring age-appropriate model systems
Research Applications
Animal models enable researchers to:
Study disease initiation and progression mechanisms
Test therapeutic interventions before human trials
Investigate regional vulnerability patterns
Examine cell-type specific pathology
Validate biomarkers and therapeutic targets
Rodent Models
Transgenic Mouse Models
P301L Tau Transgenic Models
The P301L mutation in MAPT ( microtubule-associated protein tau) was first identified in frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and has been extensively used in tauopathy research:
JNPL3 mice: Express P301L human tau under the prion protein promoter
Develop neurofibrillary tangles in spinal cord and brainstem
Show progressive motor dysfunction
Limited relevance to PSP due to 3R/4R tau mix
rTg4510 mice: Inducible expression of P301L tau
Allows temporal control of tau expression
Shows hippocampal and cortical pathology
Used for therapeutic intervention studies
4R-Tau Specific Models
Several groups have developed models specifically expressing 4R tau:
Line 1 (L1) mice: Express human 4R tau with P301L mutation
Show accumulation of 4R tau in gray matter
Develop NFT-like pathology in specific brain regions
Model recapitulates some PSP-like features
hTau4R mice: Human 4R tau genomic construct
Human tau coding region with alternative exon 10 inclusion
Avoids murine tau interference
Shows age-dependent tau pathology
Knock-in Models
Recent advances have enabled precise genetic knock-in:
MAPT KI models: Endogenous mouse MAPT replaced with human MAPT variants
Express physiological levels of tau
Avoid overexpression artifacts
Currently being developed for PSP-specific mutations
Rodent PSP Models by Induction
AAV-Mediated Tau Expression
Adeno-associated virus (AAV) vectors allow localized, cell-type specific tau expression:
AAV-hTau-P301L injection: Direct injection into specific brain regions
Targets globus pallidus, subthalamic nucleus
Recreates regional vulnerability patterns
Useful for studying circuit-specific dysfunction
AAV-4R tau: Expresses 4R tau isoform specifically
More closely mimics PSP tau isoform distribution
Can be targeted to specific neuronal populations
Tau Seed Propagation Models
Recent models exploit the prion-like propagation of tau pathology:
Inoculation models: Brain homogenate from PSP brains injected into rodents
Shows templated tau pathology
Demonstrates strain-specific propagation
Technical challenges with species barriers
Non-Rodent Mammalian Models
Rabbit Models
Rabbits have been used for tauopathy research due to their closer physiology to humans:
Tau transgenic rabbits: Express human tau isoforms
Develop age-dependent tau pathology
Show some features of 4R tau accumulation
Useful for studying cerebrovascular interactions
Ferret Models
Ferrets offer advantages for studying brainstem circuitry:
Natural susceptibility to 4R tau: Ferrets express predominantly 4R tau naturally
Brainstem architecture: Similar organization to human brainstem nuclei
Behavioral readouts: Well-characterized motor and cognitive behaviors
Non-Human Primates
Non-human primates (NHPs) provide the closest models to human physiology: